Contemporary Management of Early-Stage Melanoma: A Systematic Review
Sign Up to like & getrecommendations! Published in 2017 at "JAMA Facial Plastic Surgery"
DOI: 10.1001/jamafacial.2016.1846
Abstract: Importance The incidence of melanoma is increasing, with 76 380 new cases of invasive melanoma and 68 480 new cases of melanoma in situ expected in 2016. Objective To review the contemporary management of early-stage melanoma. Evidence… read more here.
Keywords: melanoma; stage melanoma; management; review ... See more keywords
Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2017.3462
Abstract: Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma The management of advanced melanoma has witnessed dramatic changes in recent years with the rational development of novel… read more here.
Keywords: immune checkpoint; stage melanoma; association first; patients stage ... See more keywords
Early‐stage melanoma and hematopoietic stem cell transplantation outcomes
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2018.07.010
Abstract: structure encroaching at least 0.5 mm into the arterial lumen or having a thickness greater than 50% of the surrounding intima-media thickness. Table I exhibits the anthropometric, clinical, and biochemical data of participants. To our… read more here.
Keywords: patients psoriasis; stage melanoma; stem cell; hematopoietic stem ... See more keywords
Patient Symptoms Are the Most Frequent Indicators of Recurrence in Patients with American Joint Committee on Cancer Stage II Melanoma.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American College of Surgeons"
DOI: 10.1016/j.jamcollsurg.2016.12.038
Abstract: BACKGROUND Patients with stage II melanoma have a considerable risk for recurrence. Current guidelines are imprecise as to optimal follow-up. We hypothesized that by examining recurrence patterns, we could help to better inform guidelines. STUDY… read more here.
Keywords: symptoms frequent; patient symptoms; recurrence; stage melanoma ... See more keywords
Immunotherapy: Reality check for nivolumab in advanced-stage melanoma
Sign Up to like & getrecommendations! Published in 2017 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/nrclinonc.2017.112
Abstract: targeting PD-1, is an immunotherapeutic agent commonly used as a systemic therapy for patients with advanced-stage melanoma. The importance of a well-planned treatment regimen to the outcomes of patients receiving this agent has been highlighted… read more here.
Keywords: progression; group; advanced stage; stage melanoma ... See more keywords
Pembrolizumab reduces recurrence risk in stage II melanoma
Sign Up to like & getrecommendations! Published in 2022 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/s41571-022-00638-w
Abstract: 0123456789();: suggests that pembrolizumab can eradicate micrometastatic disease, which might ultimately translate into an overall survival benefit. Pembrolizumab was associated with mostly low-grade adverse events, with grade 3–4 toxicities in only 16% of patients (compared… read more here.
Keywords: pembrolizumab; reduces recurrence; pembrolizumab reduces; stage melanoma ... See more keywords
Connective tissue panniculitis and vitiligo in a with patient stage IV melanoma achieving complete response to dabrafenib and trametinib combination therapy.
Sign Up to like & getrecommendations! Published in 2021 at "Melanoma research"
DOI: 10.1097/cmr.0000000000000787
Abstract: The combination of BRAF and MEK inhibitors, such as dabrafenib and trametinib, respectively, is an established treatment option for patients with advanced BRAFV600-mutated melanoma. With the wide adoption of these therapies, a range of cutaneous… read more here.
Keywords: combination; achieving complete; melanoma; stage melanoma ... See more keywords
Survival of stage IV melanoma in Belgium and the Netherlands
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.17668
Abstract: With interest we read the paper by Reyn et al. [1] in which the authors describe striking differences in melanoma incidence and survival between Belgium and The Netherlands. read more here.
Keywords: survival stage; belgium netherlands; belgium; melanoma belgium ... See more keywords
Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0–II) melanoma
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2021-054337
Abstract: Introduction Fear of cancer recurrence (FCR) is commonly reported by patients diagnosed with early-stage (0–II) melanoma and can have a significant impact on daily functioning. This study will pilot the implementation of the Melanoma Care… read more here.
Keywords: cancer recurrence; fear cancer; melanoma; care ... See more keywords
Patterns in progression from early stage melanoma to late stage melanoma: Implications for survivorship follow up.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e24055
Abstract: e24055Background: Despite an encouraging 99% five-year survival in patients diagnosed with early-stage melanoma, a higher proportion of fatal melanomas initially present with thin ( < 1mm) rather t... read more here.
Keywords: progression early; stage melanoma; patterns progression; early stage ... See more keywords
Outcomes of stage IV melanoma in the era of immunotherapy (IO): A National Cancer Database (NCDB) analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e21520
Abstract: e21520 Background: The majority of data for IO in melanoma stems from trials that have specific inclusion criteria and often exclude important populations. In this analysis, we present the first real-world evidence of outcomes for… read more here.
Keywords: outcomes stage; 2015 2017; 2011 2014; stage melanoma ... See more keywords